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Previous work has demonstrated the importance of genetic factors and stress-sensitive circuits in the development of affective disorders.
Anxiety and numerous psychological disorders are comorbid with substance abuse, and noradrenergic signaling in the bed nucleus of the
stria terminalis (BNST) is thought to be a source of this convergence. Here, we examined the effects of different stressors on behavior
and norepinephrine dynamics in the BNST of rat strains known to differ in their HPA-axis function. We compared the effects of acute
morphine dependence and social isolation in non-anxious Sprague Dawley (SD) rats, and a depression model, Wistar-Kyoto (WKY) rats.
We found a shared phenotype in drug-dependent and singly housed SD rats, characterized by slowed norepinephrine clearance,
decreased autoreceptor function, and elevated anxiety. WKY rats exhibited changes in anxiety and autoreceptor function only following
morphine dependence. To ascertain the influence of LC inhibition on this plasticity, we administered the LC-terminal-selective toxin
DSP-4 to SD and WKY rats. DSP-4-treated SD rats demonstrated a dependence-like phenotype, whereas WKY rats were unchanged.
Overall, our findings suggest that individuals with varying stress susceptibilities have different noradrenergic signaling changes in response
to stress. These changes may establish conditions that favor stress-induced reinstatement and increase the risk for addiction.








































Researchers have demonstrated the importance of central
noradrenergic activation in regulating behavioral and phy-
siological responses to stress (Cecchi et al, 2002; Fendt et al,
2005). In part, this is because norepinephrine can engage
the hypothalamic-pituitary-adrenal (HPA) axis. Through
such actions, norepinephrine has been identified as an
important neural substrate associated with the aversive
components of morphine withdrawal (Delfs et al, 2000).
Such evidence has given support to the view that the negative
affect experienced during drug withdrawal is mediated in
part by norepinephrine, and can contribute to the addiction
cycle (Koob and Volkow, 2010). Interestingly, a number of
psychological disorders and addictions are comorbid with
stress and involve noradrenergic dysregulation (eg, post-
traumatic stress disorder) (Hyman et al, 2006; Sinha, 2008).
For example, exposing rats to intruder stress evokes an
opiate-dependent like state and alters firing of norepinephrine
neurons (Chaijale et al, 2013). Therefore, investigation
of noradrenergic systems and their role in the initiation/
termination of stress is important for understanding the
pathophysiology of diseases that co-express with addiction.
The ventral bed nucleus of the stria terminalis (vBNST) is
a major target of norepinephrine innervation within the
brain (Kilts and Anderson, 1986). Here, forebrain, limbic,
and brainstem inputs converge to relay information about
both physical and psychological stressors. The BNST
receives small noradrenergic input from the locus coeruleus
(LC), and major noradrenergic innervation from the A1 and
A2 (via the ventral noradrenergic bundle) cell groups, and
projects to stress and reward centers (Forray and Gysling,
2004; Drolet, 2009). The BNST has neurons containing
corticotropin-releasing factor (McElligott et al, 2010),
excitatory and inhibitory projections to the paraventricular
nucleus of the hypothalamus (Choi et al, 2007), and activates
the HPA axis (Forray and Gysling, 2004). Norepinephrine is
released in the BNST during restraint stress, oral adminis-
tration of an aversive tastant, and during morphine with-
drawal (Fuentealba et al, 2000; Pardon et al, 2002; Park
et al, 2012). Thus, norepinephrine release in the BNST
can integrate stressful and aversive stimuli to generate an
appropriate physiological response.
Previously, we showed that two different rat strains,
Sprague-Dawley and Lewis, markedly differed in the response
of their noradrenergic system to morphine withdrawal
(McElligott et al, 2013). Sprague-Dawley rats demonstrated
profound plasticity of uptake and autoreceptor function,
whereas control mechanisms were unchanged in Lewis rats.
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To better understand how genetic differences interact with
drug withdrawal and stressors, we chose to compare the
stress responses of Sprague-Dawley (SD) and Wistar-Kyoto
(WKY) rats. WKY rats exhibit increased depressive
phenotypes and HPA axis function relative to Sprague-
Dawley rats (Cohen et al, 2006; Carr and Lucki, 2010), and
under restraint-stress, extracellular norepinephrine varies
between the two (Pardon et al, 2002). Here, we used fast-
scan cyclic voltammetry to evaluate differences in norepi-
nephrine overflow and regulation between SD and WKY
rats in response to stress. We subjected animals to acute
morphine-dependence, 2 weeks of social-isolation, and
DSP-4 lesioning. In response to these stressors, we found
robust neurochemical changes that differed between strains
and corresponded with anxiety-like behavior.
METHODS
Animal Care
Experiments were performed in accordance with University
of North Carolina at Chapel Hill (UNC) Institutional Animal
Care and Use Committee’s guidelines. Subjects were Sprague-
Dawley and Wistar-Kyoto rats (males, 250–350 g on arrival
from Charles River, Wilmington, MA) pair-housed in UNC
animal facilities on a 12-hour day/light cycle. Animals were
given ad libitum access to food and water, and their health
was monitored daily during treatments. For social isolation,
after 1-week of acclimation, subjects were randomly split into
single or pair-housing for 2 weeks. Care was taken to reduce
the number of animals used. For anesthetized voltammetry
experiments, 108 Sprague-Dawley and 103 Wistar-Kyoto rats
were used. A separate group of 32 Sprague-Dawley and 48
Wistar-Kyoto rats was used for anxiety measures on the
Elevated Plus Maze (EPM).
Chemicals and Drugs
Drugs were purchased from Sigma-Aldrich (St Louis, MO),
with the exception of a2C antagonist JP-1302 dihydrochloride
(Tocris Bioscience, Ellisville, MO), dissolved in sterile saline
(0.9%), and used as received. JP-1302 and a2A antagonist
BRL-44408 maleate were administered to naı̈ve animals in a
range from 0.2 to 5 mg/kg i.p. to build a dose–response curve.
Treated and control animals were given either 2 mg/kg BRL-
44408 i.p. or 2 mg/kg a2A agonist Guanfacine HCl i.p. to assay
a2A function. At the end of the experiment, animals were
given 2 mg/kg dopamine D2 antagonist raclopride tartrate
i.p., followed by 5 mg/kg a2 antagonist idazoxan i.p. to
validate signal per Park et al, 2009.
Measurement of Norepinephrine Release
Norepinephrine release in the vBNST was measured in
anesthetized animals as described previously (Park et al,
2009) (Supplementary Methods).
Elevated Plus Maze
Anxiety-like behavior was measured as described previously
(McElligott et al, 2013) (Supplementary Methods). Briefly,
the number of entries and time spent in each section of the
maze was measured over 5 min. Preference for the open
arms was determined in each animal and was expressed as a
ratio of open-arm time over closed-arm time.
Morphine Dependence
For 3 days, rats were administered 10 mg/kg morphine
sulfate s.c. once daily, followed 4 h later by 1 mg/kg
naloxone HCl to induce withdrawal. Somatic indices of
withdrawal (eg, teeth chattering) were scored each day per
Schulteis et al, 1999. Control animals received 3 days of
0.5 ml saline s.c., followed 4 h later by 1 mg/kg naloxone. On
day 4, drug-free rats were assayed on the EPM or underwent
surgery for norepinephrine measurements.
DSP-4 Lesioning
Wistar-Kyoto and Sprague-Dawley rats (150–200 g on
arrival) were pair-housed, and administered two i.p.,
50 mg/kg N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine
(DSP-4) injections in 1 ml/kg saline 3 days apart. Control
animals were given two 1 ml/kg i.p. saline injections 3 days
apart. Animals were allowed to recover for 410 days after
the last injection.
Statistics
Results are presented as average values±SEM. Two-way
analysis of variance (ANOVA) with post hoc Bonferroni
tests were used to determine statistical significance. An
unpaired t-test was used to determine differences in anxiety
between morphine-dependent and control WKY rats.
Differences were considered significant when *Po0.05,
**Po0.01, ***Po0.005.
RESULTS
First, we chose to extend prior work demonstrating strain-
dependent differences in norepinephrine regulation during
stress (Pardon et al, 2002; McElligott et al, 2013). We
characterized vBNST norepinephrine synaptic function in
anesthetized WKY rats with electrical stimulations of the
ventral noradrenergic bundle, and measured subsequent
norepinephrine overflow with fast-scan cyclic voltammetry
(Park et al, 2009; Herr et al, 2012). This technique allows
characterization of release and uptake of biogenic amines
(John et al, 2006). We measured norepinephrine by placing
the carbon-fiber microelectrode directly beneath the ante-
rior commissure (electrode placement shown in Figure 1a,
sample color plot encoding voltammetric recordings in
Figure 1b). Release increased linearly with increasing
stimulation duration in WKY rats (60 Hz stimulations,
r2¼ 0.99, slope: 3.71±0.24; Figure 1c) similar to our
findings in SD rats (slope: 3.11±0.21, McElligott et al,
2013). Despite known phenotypic variations (Carr and
Lucki, 2010), we found no differences in norepinephrine
clearance (t1/2) between WKY and SD rats in a baseline state
(1.6±0.12 s vs 1.7±0.10 s, n¼ 22 and 26, respectively).
The adrenergic a2 receptor serves as the inhibitory
autoreceptor for norepinephrine, and two differentially
regulated subtypes are present in the BNST (Scheinin et al,
1994). We assayed autoreceptor influence on release with a2
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antagonist idazoxan in WKY and SD rats. After drug
administration (5 mg/kg), the amplitude in evoked nor-
epinephrine ([NE]max) was increased similarly in both
strains (WKY: 205±10.3% vs SD: 216±21.1%, n¼ 6 and 5,
respectively). To examine a2 subtype-specific effects, we
employed a2A and a2C selective antagonists BRL-44408 and
JP-1302, respectively. We found increased evoked norepi-
nephrine in WKY rats following 2 mg/kg BRL-44408, but
not 2 mg/kg JP-1302 (examples in Figure 1e and f, BRL:
140±6.9% vs JP: 95±4.5%, n¼ 5). Similar effects were
found in SD rats: (BRL: 157±15.4%. vs JP: 102±7.3%, n¼ 5
and 6, respectively). The selected doses (2 mg/kg) approach
saturation (Supplementary Figure 1) and are sufficient to
produce robust behavioral effects in vivo (Sallinen et al,
2007). Thus, our findings indicate the a2A subtype is the
principle noradrenergic autoreceptor in the vBNST of
both WKY and SD rats, and it exerts similar control over
norepinephrine release in both strains.
Norepinephrine Dynamics were Differentially Altered in
Morphine-Dependent SD and WKY Rats
We hypothesized that SD and WKY rats would not differ in
their response to morphine-dependence, owing to their
noradrenergic similarity in a baseline state. To compare
noradrenergic plasticity, we established morphine-depen-
dence in SD and WKY rats as before (Schulteis et al, 1999;
McElligott et al, 2013). Briefly, rats received 10 mg/kg
morphine followed 4 h later by 1 mg/kg naloxone once daily
for 3 days. Consistent with our prior work, withdrawal was
behaviorally evident in both strains by day 3 (Supplemen-
tary Figure 2). On day 4, rats were anesthetized and electri-
cally evoked norepinephrine was recorded. First, we examined
the effects on norepinephrine clearance and found clearance
half-life showed a main effect of strain (F¼ 5.8, Po0.05) and
treatment (F¼ 5.8, Po0.05). There was also a significant
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Figure 1 Fast-Scan Cyclic Voltammetry of norepinephrine in the ventral bed nucleus of the stria terminalis (vBNST). (a) Electrode tract (dashed line) and
representative histology of carbon-fiber electrode placement in the vBNST (dashed circle; DS, dorsal striatum; AC, anterior commissure).
(b) Norepinephrine measured in the vBNST after electrical stimulation (white bar). The cyclic voltammogram (current vs potential) is obtained from
the white dashed line, and the concentration vs time trace from the black dashed line. (c) Input-output curve of [NE]max at 20, 40, 60, 80, and 120 stimulation
pulses in WKY rats. (d) Representative concentration traces comparing norepinephrine release and uptake in SD and WKY rats. (e and f) Representative
color plots of electrically evoked norepinephrine in the vBNST with a2A (BRL), a2C (JP), and non-selective a2 (IDA) antagonists on board in WKY rats.
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Po0.01). In agreement with our previous work, morphine-
dependent SD rats showed impaired uptake relative to con-
trols (2.2±0.16 s vs 1.5±0.06 s, n¼ 12 and 11, respectively,
Po0.001). To our surprise, uptake was unaltered in WKY
rats (1.5±0.14 s vs 1.6±0.10 s, n¼ 9 and 10, respectively,
P40.05, Figure 2a). As before, the protocol we employed
allows time for clearance of morphine and naloxone
(Trescot et al, 2008), thus altered uptake in SD rats is a
consequence of morphine withdrawal.
To assay the effects of morphine withdrawal on a2A func-
tion in these two strains, we administered 2 mg/kg of selec-
tive antagonist BRL-44408, or agonist guanfacine (2 mg/kg,
GFC) and determined the effects on release. The doses were
selected based on dose–response analysis in Supplementary
Figure 1 and 3. Response to autoreceptor drugs showed a
main effect of morphine treatment (two-way ANOVA, BRL:
F¼ 26, Po0.0005; GFC: F¼ 18.2, Po0.005) and strain
(two-way ANOVA, GFC: F¼ 4.7 Po0.05). Post hoc analysis
revealed a significant decrease in response to BRL between
morphine-dependent animals and their saline-naloxone
controls (SD: 102±3.5% for morphine withdrawal vs
167±9.1% for control, n¼ 7, respectively, Po0.001; WKY:
104±6.5% for morphine withdrawal vs 147±6.4% for
control, n¼ 7, respectively, Po0.001, Figure 2b). Addition-
ally, the a2A agonist, GFC, was less effective at inhibiting
evoked norepinephrine release in both strains (SD:
87±3.6% for morphine withdrawal vs 65±4.9% for control,
n¼ 7, respectively, Po0.05; WKY: 102±8.9% for morphine
withdrawal vs 75±3.8% for control, n¼ 7, respectively,
Po0.01, Figure 2c). Thus, following morphine withdrawal,
a2A function is desensitized in both SD and WKY rats.
WKY and SD Rats Exhibited Increased Anxiety-Like
Behavior following Morphine-Dependence
We previously showed that morphine withdrawal increases
anxiety-like behavior in SD rats (McElligott et al, 2013). To
examine its impact on WKY rats, we assayed their behavior
on the EPM. Withdrawal caused WKY rats to become more
anxious, as they had reduced preference for the open arms
compared with their saline-naloxone controls (unpaired
t-test, Open/Closed time: 0.05±0.03 vs 0.39±0.12, n¼ 8,
respectively, Po0.01, Table 1). WKY rats treated with
saline-naloxone did not demonstrate a change in open-arm
preference relative to naı̈ve animals (Table 2, pair-housed).
Social-Isolation Altered Norepinephrine Signaling in
SD, but not WKY Rats
To further investigate differences between SD and WKY
norepinephrine responses, we treated rats with chronic
social isolation. This is a passive stressor that removes
injection/handling stress, and is suggested to generate
depression in rodents (Nestler and Hyman, 2010; Butler
et al, 2014). Following 2 weeks of single-housing, rats were
anesthetized and evoked norepinephrine was recorded.
When comparing norepinephrine uptake between single (S)
and pair (P)-housed animals, we found significantly slower
uptake in SD-S rats compared with SD-P (2.3±0.09 s vs
1.7±0.10 s, n¼ 20 and 26, respectively, Po0.001). However,
WKY-S did not slow uptake relative to pair-housed controls
(1.6±0.06 s vs 1.6±0.12 s, n¼ 21 and 22, respectively,
P40.05, Figure 3a).
We next compared a2A drug effects between single and
pair-housed animals, and found a main effect of housing
(two-way ANOVA, BRL: F¼ 24.12, Po0.0001; GFC: F¼ 7.2,
Po0.05) and a housing strain interaction (BRL: F¼ 8.2,
Po0.01; GFC: F¼ 5.4, Po0.05). Post hoc analysis revealed
that BRL was less effective in increasing norepinephrine in
SD-S animals as compared with SD-P (97±1.4% vs 158±
11.9%, n¼ 7, respectively, Po0.001, Figure 3b). Similarly,
the decrease in release following GFC was attenuated in
single-housed animals (91±3.2% vs 64±7.9%, n¼ 7,
respectively, Po0.01, Figure 3c). WKY-S failed to decrease
drug response when compared with WKY-P rats (BRL:
124±8.9% vs 140±4.8%, n¼ 7 respectively, P40.05; GFC:
78±6.4% vs 76±2.2%, n¼ 7, respectively, P40.05).
Social Isolation Induces Anxiety-Like Behavior in SD Rats
We assayed anxiety-like behavior in singly housed animals
on the EPM. Enclosed arm time showed a main effect of
Figure 2 The effects of morphine dependence in Sprague-Dawley and
Wistar-Kyoto rats. (a) Average norepinephrine clearance as measured
by t1/2. (b and c) Average evoked norepinephrine ([NE]max) following
administration of 2 mg/kg BRL-44408 (b), or guanfacine (GFC) (c) relative
to pre-drug stimulated release. Data are presented as mean±SEM.
Bonferroni post hoc analysis: *Po0.05, **Po0.01, ***Po0.005.
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strain (two-way ANOVA, F¼ 8.24, Po0.01) and a
housing strain interaction (F¼ 4.89, Po0.05). Open arm
time showed a main effect of housing (F¼ 4.83, Po0.05).
Total number of entries showed a main effect of strain
(F¼ 6.11, Po0.05), and the reduced number of WKY
entries agrees with previous studies (Cohen et al, 2006; Carr
and Lucki, 2010). Post hoc analysis revealed a significant
reduction in open arm preference in single-housed animals
(Open time/Closed time: 0.33±0.09 vs 0.12±0.05, SD-S vs
SD-P, n¼ 8 and 7, respectively, Po0.05). WKY-S did not
increase anxiety-like behavior relative to WKY-P rats
(Table 2).
Coerulean Lesion Induced Noradrenergic Plasticity in
SD Rats, but not WKY
As both morphine dependence and social stress can alter
the firing rate of the LC (Chaijale et al, 2013; Van Bockstaele
and Valentino, 2013), we wanted to mimic the effects of
long-term LC inhibition on BNST norepinephrine and
behavior. We lesioned coerulean norepinephrine terminals
using the neurotoxin DSP-4, which reduces norepinephrine
from LC but not medullary cells (Fritschy and Grzanna,
1989). The vBNST receives little LC input, and stimulation
electrode placement in the ventral noradrenergic bundle
targets axons primarily from A1/A2 cell groups. Not
surprisingly, [NE]max was unchanged by DSP-4 treatment
(SD: 219±37 nM vs 322±87 nM, n¼ 7, and 6, respectively,
P40.05; WKY: 230±23 nM vs 239±19 nM, n¼ 7 and 5,
respectively, P40.05). However, differences in synaptic
function were found between vehicle and DSP-4-treated SD
rats. Clearance half-life showed a strain treatment inter-
action (F¼ 9.5, Po0.01) and main effect of strain (F¼ 13.2,
Po0.005). DSP-4-treated SD rats had slower uptake than
their controls (2.6±0.27 s vs1.6±0.15 s, n¼ 7 and 8, respec-
tively, Po0.01). WKY rats were unchanged (1.1±0.23 s vs
1.5±0.22 s, n¼ 5 and 8, respectively, P40.05, Figure 4a).
Response to both BRL and GFC showed a strain treatment
interaction (two-way ANOVA, BRL: F¼ 6.7, Po0.05; GFC:
F¼ 4.5, Po0.05), and main effect of treatment (BRL:
F¼ 11.9, Po0.01; GFC: F¼ 5.8, Po0.05). Post hoc analysis
revealed the response to BRL and GFC was blunted in DSP-4
Table 1 Anxiety-like Behavior Following Morphine Withdrawal in WKY Rats
Morphine dependence Ratio Open/Closed time Total entries Open time Closed time
Wistar-Kyoto
Saline-Naloxone (n¼ 8) 0.39±0.12 6±1 22±4 s 76±14 s
Morphine-Naloxone (n¼ 8) 0.05±0.03* 6±1 6±3 s* 126±24 s
Total number of entries and time spent in the open and enclosed arms of the elevated plus maze was evaluated. An animal’s preference for open arms was expressed
as a ratio of open-arm time over closed-arm time. Data are presented as mean±SEM. Treated WKY were compared with their controls using an unpaired t-test.
Starred values denote significance between the treated group and the control directly above it. *Po0.05.
Table 2 Anxiety-like Behavior Following Differing Stressors
Ratio Open/Closed time Total entries Open time Closed time
Social isolation
Sprague-Dawley
Pair-housed (n¼ 7) 0.33±0.09 14±1 49±11 s 163±10 s
Single-housed (n¼ 8) 0.12±0.05* 12±2 20±7 s* 201±12 s*
Wistar-Kyoto
Pair-housed (n¼ 8) 0.26±0.06 9±2 38±8 s 156±10 s
Single-housed (n¼ 8) 0.23±0.04 9±1 32±6 s 148±9 s
Coerulean Lesioning
Sprague-Dawley
Saline (n¼ 8) 0.26±0.01 15±2 47±6 s 165±8 s
DSP-4 lesioned (n¼ 8) 0.12±0.03* 6±2* 25±6 s* 207±15 s*
Wistar-Kyoto
Saline (n¼ 8) 0.17±0.05 6±1 25±8 s 162±8 s
DSP-4 lesioned (n¼ 7) 0.13±0.03 7±3 24±4 s 193±14 s
Total number of entries and time spent in the open and enclosed arms of the elevated plus maze was evaluated. An animal’s preference for open arms was expressed
as a ratio of open-arm time over closed-arm time. Data are presented as mean±SEM. Treated animals were compared with their controls using a two-way ANOVA
with Bonferroni post hoc analysis. Differences in anxiety following stress were determined for each strain by comparing treated animals with their respective controls.
Starred values denote significance between the treated group and the control directly above it. *Po0.05.
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treated SD rats (BRL: 100±5.3% vs 155±14.7%, n¼ 5,
respectively, Po0.05; GFC: 90±2.8% vs 64±7.9%, n¼ 5
and 7, respectively, Po0.01) but not WKY rats (BRL:
130±6.4% vs 138±7.2% n¼ 5, respectively, P40.05;
GFC: 80±3.8% vs 78±1.3% n¼ 5, respectively, P40.05,
Figure 4c).
Coerulean Lesion Increased Anxiety-Like Behavior in
SD Rats
The impact of DSP-4 lesioning on anxiety is dependent
on dosage, recovery, and housing (Harro et al, 1995; Lapiz
et al, 2001; Itoi et al, 2011). Our treatment increased
anxiety-like behavior in SD rats, but not WKY rats as
measured on the EPM. DSP-4-treated SD rats spent less time
in the open arms, and more time in the enclosed arms
(Open time/Closed time: 0.12±0.03 vs 0.26±0.01, n¼ 8,
DSP-4 vs saline, respectively, Po0.05. The number of
entries was also reduced (6±2 vs 15±2, n¼ 8, respectively,
Po0.05). DSP-4-treated WKY rats did not show increased
anxiety compared with controls (Table 2).
DISCUSSION
Extracellular neurotransmitter concentrations are balanced
by release and uptake processes (Wightman et al, 1988).
Norepinephrine release is controlled by both cell firing and
autoreceptor modulation, and the norepinephrine trans-
porter is the primary clearance mechanism (Xu et al, 2000)
with metabolism operating on a slower time scale (Near
et al, 1988). Previously, we showed Lewis rats have hindered
uptake, blunted autoreceptor function (McElligott et al,
2013), and increased anxiety compared with SD rats. When
Figure 3 The effects of social isolation in Sprague-Dawley and Wistar-
Kyoto rats. (a) Average norepinephrine clearance as measured by t1/2.
(b and c) Average evoked norepinephrine ([NE]max) following administra-
tion of 2 mg/kg BRL-44408 (b), or guanfacine (GFC) (c) relative to pre-drug
stimulated release. Data are presented as mean±SEM. Bonferroni post hoc
analysis: *Po0.05, **Po0.01, ***Po0.005.
Figure 4 The effects of coerulean lesioning in Sprague-Dawley and
Wistar-Kyoto rats. (a) Average norepinephrine clearance as measured by
t1/2. (b and c) Average evoked norepinephrine ([NE]max) following
administration of 2 mg/kg BRL-44408 (b) or guanfacine (GFC) (c) relative
to pre-drug stimulated release. Data are presented as mean±SEM.
Bonferroni post hoc analysis: **Po0.01.
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stressed with morphine withdrawal, Lewis rats showed no
change in the regulation of BNST norepinephrine. This was
in contrast to the dramatic alterations in norepinephrine
clearance rate and autoreceptor function found in drug-
dependent SD rats (McElligott et al, 2013). Here, we show
that naı̈ve SD and WKY rats are indistinguishable from each
other with respect to evoked norepinephrine overflow,
however, each strain diverges in their adaptations to stress.
We found that following morphine withdrawal, WKY rats
were similar to SD rats with increased anxiety and attenuated
autoreceptor function, however, norepinephrine uptake rate
in WKY rats was unaltered. Additionally, BNST norepi-
nephrine control mechanisms were unchanged in socially
isolated WKY rats, whereas SD rats challenged with social
isolation became more anxious and exhibited exacerbated
norepinephrine signaling. Following lesions of norepi-
nephrine in the LC, SD rats showed reduced norepinephrine
control and increased anxiety, surprisingly similar to acute
morphine dependence, but WKY rats were unaffected.
Overall, we find WKY rats respond only to select stressors
and that anxiety correlates with the degree of regulation of
extracellular norepinephrine in the BNST.
The a2 receptors are the primary adrenergic autorecep-
tors, and they show subtype-specific desensitization and
phosphorylation by G-protein receptor kinases (Jewell-Motz
and Liggett, 1996). As two subtypes of a2 receptors are
expressed in the BNST (Scheinin et al, 1994), we paired
fast-scan cyclic voltammetry measurements with receptor-
subtype-specific pharmacology to assay control over nor-
epinephrine release by each subtype. Knock-out mice were
used to determine that a2A acts as the principle autoreceptor
(Trendelenburg et al, 2001). In agreement with this, we
found the inhibition of a2A increased norepinephrine
overflow in the vBNST to a similar extent in both rat
strains. Although blockade of a2C receptors did not increase
norepinephrine overflow, a2C inhibition generated a large
alkaline flux following stimulated norepinephrine release,
seen in Figure 1f as blue current just below norepinephrine
peak oxidation potential. The a2C receptors in the vBNST
may therefore be positioned to regulate blood flow/
metabolism in the vBNST (Bucher et al, 2014).
WKY rats exhibit reduced locomotion in an open field,
limited exploration in the EPM, low baseline startle, and
limited stress responsivity as compared with SD rats
(Pardon et al, 2002; Cohen et al, 2006). Correspondingly,
increases in extracellular norepinephrine in the BNST, eva-
luated by microdialysis, were greater in SD during restraint
stress than WKY rats (Pardon et al, 2002). Following the
stresses of both social isolation and morphine withdrawal,
we found in SD rats that uptake and autoreceptor regulation
are downregulated. The decreased noradrenergic control in
SD rats could generate the comparatively larger increase
in extracellular norepinephrine found with microdialysis. In
WKY rats, morphine withdrawal produced only attenuated
autoreceptor function, whereas social stress had no effect on
norepinephrine control mechanisms. These limited adapta-
tions would result in the smaller alteration in the level of
extracellular norepinephrine induced by stress (Pardon
et al, 2002). Importantly, cellular activation in the BNST
during stress is similar between the two strains (Ma and
Morilak, 2004). Thus, the greater norepinephrine overflow
others have measured in stressed SD likely reflect the
changes in uptake rate and desensitized autoreceptors
revealed in this work.
Non-specific organic cation transporters (OCTs) are
expressed throughout the BNST (Gasser et al, 2009). The
high-capacity, low-affinity OCT3 is thought to act as a
secondary means of norepinephrine clearance, and is
inhibited by physiological levels of corticosterone (Gasser
et al, 2006). The extent to which BNST norepinephrine is
taken up by OCTs in vivo is not currently known, however,
NET knockout mice still demonstrate catecholamine
clearance in brain slices (Xu et al, 2000) relative to dopamine
transporter knockouts (Giros et al, 1996), indicating this
may be a significant clearance mechanism for norepinephr-
ine. Previously, we showed the altered norepinephrine
clearance in SD rats following withdrawal was not due to
decreased NET binding sites (McElligott et al, 2013).
Instead, stress-induced corticosterone release may inhibit
OCT3 and reduce clearance rate. WKY rats have elevated
peak diurnal levels of corticosterone relative to SD rats
(Rittenhouse et al, 2002), which may eliminate any OCT3
component of norepinephrine uptake because of chronic
inhibition. In addition, WKY rats exhibit behavioral sensi-
tivity to the NET inhibitor desipramine (Lopez-Rubalcava
and Lucki, 2000), highlighting the importance of NET in
WKY rats. The unaltered norepinephrine uptake in WKY
rats corresponds with their low stress responsivity, and is
likely the result of HPA axis dysfunction.
Social stressors promote drug self-administration and
escalation, generate a long-lasting tolerance to opiate ana-
lgesia, and are as efficacious as physical stress at reinstating
morphine place preference (Miczek et al, 2004; Ribeiro Do
Couto et al, 2006; Butler et al, 2014). Exposure to stressful
life events and HPA axis dysfunction have been implicated
in the development of several psychiatric disorders that
are comorbid with addiction, however, stress alone is not
sufficient for their development (Faravelli et al, 2012). It
has been suggested that stress can interact with genetic
vulnerabilities in predisposed individuals to create the
psychopathology. Valentino and coworkers(Chaijale et al,
2013) found stress activation of the endogenous opioid
system sufficient to generate a cellular opiate dependence
in SD rats. Here, we used chronic social isolation, a passive
stressor suggested to induce depression and anxiety in
rodents (Nestler and Hyman, 2010; Butler et al, 2014).
Remarkably, after SD rats were socially isolated for 2 weeks,
they resembled morphine-dependent SD rats, with in-
creased anxiety and enhanced noradrenergic signaling in
the vBNST. Moreover, following social isolation, SD rats
anxiety and norepinephrine regulation resembled that of
our previous work in Lewis rats (McElligott et al, 2013), a
model of increased drug-intake and PTSD (Cohen et al,
2006; Sanchez-Cardoso et al, 2007; Picetti et al, 2012). In
stark contrast, we found that WKY rats were unresponsive
to social isolation, exhibiting no changes in anxiety-like
behavior or norepinephrine signaling relative to their
controls. These results support the idea that genetic differ-
ences can predispose individuals to psychological disorders
or addictions, as their noradrenergic system may already
resemble a drug-dependent or anxious state. Additionally,
individuals with anxiety or depression may not be able to
appropriately adapt to stress because of low responsivity of
the noradrenergic system.
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During stress, LC activity is tuned by a balance of CRF
excitation, and endogenous opioid inhibition (Van Bockstaele
and Valentino, 2013), and chronic stress can decrease LC
discharge rates (Chaijale et al, 2013). The BNST receives a
small input from the LC (Forray and Gysling, 2004), and its
activation may be influenced by altered coerulean discharge
rates following stress. Thus, we chose to mimic stress-
induced LC inhibition by lesioning it with the potent and
selective neurotoxin DSP-4. DSP-4 induces degradation of
norepinephrine axons arising from the LC, while leaving
brainstem norepinephrine innervation intact (Fritschy and
Grzanna, 1989). The behavioral effects of DSP-4 treatment
are variable (Harro et al, 1995; Lapiz et al, 2001; Itoi et al,
2011), and in our study, we found an anxiogenic effect in SD
rats with no change in WKY rats relative to their respective
controls. This LC inhibition also lowered the number of
maze entries SD rats made to that of WKY. Surprisingly,
the DSP-4 treatment produced a robust, dependence-like
phenotype in the BNST norepinephrine regulation of SD
rats. Such a response was not expected owing to the limited
LC innervation of the BNST. These results may reflect feed-
back between the two main sources of central noradrenergic
innervation through a common afferent (Van Bockstaele
and Valentino, 2013) and should be a point of future study.
Cross-talk between noradrenergic inputs is supported by
work demonstrating the importance of both medullary and
coerulean norepinephrine in mediating the aversiveness
(Delfs et al, 2000) and somatic withdrawal signs of with-
drawal (Maldonado, 1997). Importantly, LC activation
during opiate withdrawal is partly a result of excitatory
input from the nucleus paragigantocellularis, a structure
that innervates the nucleus of the solitary tract (A2).
Following DSP-4 treatment, we found no change in
norepinephrine regulation in WKY rats, similar to WKY
rats exposed to social isolation stress. However, WKY rats
were responsive to morphine withdrawal, the aversiveness
of which is due to medullary norepinephrine (Delfs et al,
2000). WKY rats overexpress kappa opioid receptors in the
LC, leaving the LC in a chronically inhibited state (Carr and
Lucki, 2010), a possible explanation for the low number of
maze entries and lack of DSP-4 response. This persistent
inhibition may attenuate any excitatory influence of CRF
and partially explain the lack of noradrenergic facilitation
to social isolation. Overall, these results suggest a plasticity
of medullary inputs but not LC inputs in the BNST of
WKY rats.
We have shown that certain stressors permit exacerbated
BNST signaling that is accompanied by increased anxiety.
Furthermore, we showed the signaling changes coincide
with a2A receptor function and are dependent on rat strain.
Social isolation and persistent coerulean inhibition caused
dramatic changes in the SD rat, and generated a morphine-
dependence-like phenotype. WKY rats were unresponsive
to both social isolation and DSP-4 treatment. Following
morphine withdrawal, they demonstrated increased anxiety
and an intermediate change in norepinephrine signaling:
decreased a2A function without a change in norepinephrine
clearance. Taken together, this differential responsivity may
reflect separate noradrenergic mechanisms for adaptation
that depend on the stressor or its intensity. Moreover,
our data support the idea that genetic factors contribute
to stress response, which may in turn generate cellular
conditions that favor drug use and future substance abuse
issues.
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